(Q36063746)

11 August 2017

Cervical cancer screening in the United States and the Netherlands: a tale of two countries (English)

1 reference

11 August 2017

0 references

cervix uterine cancer

1 reference

1

Dik Habbema

1 reference

11 August 2017

Inge M C M De Kok

2

1 reference

11 August 2017

Martin L Brown

series ordinal

3

1 reference

11 August 2017

language of work or name

English

0 references

publication date

1 March 2012

1 reference

11 August 2017

1 reference

11 August 2017

90

1 reference

11 August 2017

1

1 reference

11 August 2017

5-37

1 reference

Human papillomavirus and Papanicolaou tests screening interval recommendations in the United States

11 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3385017

Cancer screening practices among physicians in the national breast and cervical cancer early detection program

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3385017

Low-risk human papillomavirus testing and other nonrecommended human papillomavirus testing practices among U.S. health care providers

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3385017

Breast and cervical cancer screening programme implementation in 16 countries

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3385017

How Medicare could use comparative effectiveness research in deciding on new coverage and reimbursement

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3385017

US physicians' intentions regarding impact of human papillomavirus vaccine on cervical cancer screening

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3385017

Data and trends in cancer screening in the United States: results from the 2005 National Health Interview Survey

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3385017

Ambulatory care visits for Pap tests, abnormal Pap test results, and cervical cancer procedures in the United States.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3385017

Comparative effectiveness and health care spending--implications for reform

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3385017

Waste in the U.S. Health care system: a conceptual framework

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3385017

Accuracy of self-reports of Pap and mammography screening compared to medical record: a meta-analysis.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3385017

Does patient health and hysterectomy status influence cervical cancer screening in older women?

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3385017

Does preventive care save money? Health economics and the presidential candidates

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3385017

Age-dependent prevalence of 14 high-risk HPV types in the Netherlands: implications for prophylactic vaccination and screening

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3385017

Prevalence of HPV infection among females in the United States

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3385017

Assessing the annual economic burden of preventing and treating anogenital human papillomavirus-related disease in the US: analytic framework and review of the literature

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3385017

The safety net: a cost-effective approach to improving breast and cervical cancer screening

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3385017

ACOG Practice Bulletin: clinical management guidelines for obstetrician-gynecologists. Number 45, August 2003. Cervical cytology screening (replaces committee opinion 152, March 1995).

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3385017

Low risk of cervical cancer during a long period after negative screening in the Netherlands

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3385017

American Cancer Society guideline for the early detection of cervical neoplasia and cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3385017

Endocervical status is not predictive of the incidence of cervical cancer in the years after negative smears

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3385017

Screening for cervical cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3385017

Cost effectiveness of cervical cancer screening for the elderly.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3385017

Cervical cancer screening with both human papillomavirus and Papanicolaou testing vs Papanicolaou testing alone: what screening intervals are physicians recommending?

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3385017

Meeting the cervical cancer screening needs of underserved women: the National Breast and Cervical Cancer Early Detection Program, 2004-2006.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3385017

Specialty differences in primary care physician reports of papanicolaou test screening practices: a national survey, 2006 to 2007.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3385017

Cervical cancer screening policies and coverage in Europe

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3385017

Pathology databanking and biobanking in The Netherlands, a central role for PALGA, the nationwide histopathology and cytopathology data network and archive.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3385017

Report from the CDC. Pap test intervals used by physicians serving low-income women through the National Breast and Cervical Cancer Early Detection Program.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3385017

Pap screening in a U.S. health plan.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3385017

Risk of Cervical Cancer Associated with Extending the Interval between Cervical-Cancer Screenings

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3385017

Cost-effectiveness of alternative triage strategies for atypical squamous cells of undetermined significance

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3385017

Cost-effectiveness of 3 methods to enhance the sensitivity of Papanicolaou testing

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3385017

Abuses in human papillomavirus DNA testing

23 September 2018

1 reference

12 December 2020

Understanding differences in the guidelines for colorectal cancer screening

1 reference

12 December 2020

Practice guidelines developed by specialty societies: the need for a critical appraisal

1 reference

12 December 2020

Does cost-effectiveness analysis make a difference? Lessons from Pap smears. Symposium

1 reference

12 December 2020

Women who participate in spontaneous screening are not at higher risk for cervical cancer than women who attend programme screening

1 reference

12 December 2020

Efficacy of cervical cytologic screening in the control of cervical cancer

1 reference

12 December 2020

Screening for squamous cervical cancer: duration of low risk after negative results of cervical cytology and its implication for screening policies. IARC Working Group on evaluation of cervical cancer screening programmes

1 reference

12 December 2020

ACOG committee opinion. Recommendations on frequency of Pap test screening. Number 152--March 1995. Committee on Gynecologic Practice. American College of Obstetricians and Gynecologists

1 reference

12 December 2020

Cervical Cancer in Women With Comprehensive Health Care Access: Attributable Factors in the Screening Process

1 reference

12 December 2020

Monitoring a national cancer prevention program: successful changes in cervical cancer screening in the Netherlands

1 reference

12 December 2020

Cost analysis of the National Breast and Cervical Cancer Early Detection Program: selected states, 2003 to 2004

1 reference

12 December 2020

No increased risk for cervical cancer after a broader definition of a negative Pap smear

1 reference

12 December 2020

ACOG Practice Bulletin no. 109: Cervical cytology screening

1 reference

12 December 2020

10.1111/J.1468-0009.2011.00652.X

Identifiers

DOI

1 reference

11 August 2017

1 reference

11 August 2017

PubMed publication ID

22428690

1 reference